Skip to main content

Texas Biologics logo

☰

  • Home
  • About
    • Overview
    • What are Biologics?
    • Executive Committee
    • News
  • Research
    • Our Approach
    • Current Projects
    • Core Facilities
    • COVID-19
    • Advanced Protein Therapeutics Core
  • Programs
    • Pilot Grants
    • Core Facility Support
    • Clinical Trials Unit
  • Commercialization
    • Therapeutics Pipeline
    • Technology Partnering
    • Commercialization Partners
    • Resources for Faculty and Students
  • Get Involved
    • Partner with Us
    • Prospective Students
    • Giving
    • Contact
  • Events
  • Home
  • About
    • Overview
    • What are Biologics?
    • Executive Committee
    • News
  • Research
    • Our Approach
    • Current Projects
    • Core Facilities
    • COVID-19
    • Advanced Protein Therapeutics Core
  • Programs
    • Pilot Grants
    • Core Facility Support
    • Clinical Trials Unit
  • Commercialization
    • Therapeutics Pipeline
    • Technology Partnering
    • Commercialization Partners
    • Resources for Faculty and Students
  • Get Involved
    • Partner with Us
    • Prospective Students
    • Giving
    • Contact
  • Events

↑

About

About

  • Overview
  • What are Biologics?
  • Executive Committee
  • News
    • In the Media

In the Media

Here are some of the biggest medical advances in 2023

ScienceNews

A Truly Amazing Vaccine Breakthrough Is Hiding in Plain Sight

The Atlantic

First RSV vaccine with UT ties expected to be available by next year

KXAN

University of Texas research initiative to advance development of biologic therapies

Austin American-Statesman

This UT Scientist Helped Spare Millions From COVID-19. Now He’s Unmasking Other Killer Viruses.

Texas Monthly

For decades, fear and failure in the hunt for an RSV vaccine. Now, success.

Washington Post

Cancer Institute grants $8.5 million to UT to further research

The Daily Texan

Biologics Market Players Evolving to New Heights in 2022 – Exclusive Report by Mordor Intelligence

Digital Journal

Inside the University of Texas at Austin lab where the leading COVID-19 vaccines were partially developed

WFAA TV

Researchers Are Hatching a Low-Cost Coronavirus Vaccine

The New York Times

UT Austin logo

©

The University of Texas at Austin | Privacy Policy | Web Accessibility

Cockrell School of Engineering
College of Natural Sciences 
Dell Medical School
Resources
  • Contact Us
  • News

Give